TNFSF11 and neoplasm: In contrast to activity in WT mice, efficacy of anti‐RANKL/PD‐1 BsAb on AT3‐OVAdim tumor growth was negated in Pdcd1−/− mice (Figure 5), indicating the requirement for host PD‐1.